This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Similar to Phillips’ idea of planning ahead, the FDA also has detailed provisions for patients to take during power outages, floods, or other events that compromise their ability to manage their medications. “An Taking precautions for storing medications and supplies is key to being prepared,” the FDA wrote. from 1999 to 2018.
More US pharmacies closed than opened in 2018–21; independent pharmacies, those in Black, Latinx communities most at risk. Stay ahead of the curve: Sign up for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips, straight to your inbox. References 1. Health Affairs.
In the cross-sectional study, investigators used data from the 2018 to 2024 Mental Health and Addiction Treatment Tracking Repository. However, data on low-dose initiation compared with traditional initiation is still limited.
Approximately 31% of people in the United States were overweight and 42% were obese in 2017 to 2018, compared with 34% and 30.5% " Obesity has risen considerably over the past 3 years, according to data from the Pew Research Center. in 1999 to 2000, respectively.
Snow — Recently, FDA announced a deadline shift, although the Agency did so quietly. Confirmatory testing remains due by August 1, 2025, but FDA has now acknowledged that full implementation of mitigation strategies—such as reformulation or the addition of new specifications—may take longer. By Charles D. What does this mean?
Buy Reports Newsletters PT News Insmed wins FDA approval for future blockbuster Brinsupri Brinsupri becomes the first bronchiectasis therapy while ushering in a new class of DPP1 inhibitors. Brinsupri has been approved to treat adults and children aged 12 years and over with NCFB. GlobalData is the parent company of Pharmaceutical Technology.
Patients were included between January 1, 2018, and January 1, 2025, and January 1, 2018, and May 1, 2025, respectively. They included data from 2 large integrated health systems, with one serving the Virginia and North Carolina area and the other covering Connecticut and Rhode Island. years at the initiation of semaglutide.
Chris Fox, Executive Vice President at Teva, said: “With this FDA approval, AJOVY now offers younger patients a new treatment option, addressing a long-standing gap in care and offering families added support as they navigate the challenges of this condition.” AJOVY was first approved in the US in 2018 for adult patients.
Jazz sings new tune with CEO switch Jazz Pharmaceuticals made history by scoring the first FDA approval for a CBD-based drug in 2018. Please select at least one newsletter.
In 2014, the US FDA approved this regimen, and it features in the latest WHO guidelines for LTBI treatment. She was the consultation lead of the UK Clinical Pharmacy Association Infection Group from 2018 to 2025 and is currently a clinical advisor for the British Thoracic Society Multi-Drug Resistant Tuberculosis Clinical Advice Service.
1 The FDA recommended that the US Drug Enforcement Administration (DEA) move medical marijuana from Schedule I to Schedule III. 2 This determination was based on the FDA’s evaluation of abuse potential, dependency, and accepted medical use for marijuana. Greenwich Biosciences; 2018. tetrahydrocannabinol (THC). REFERENCES 1.
Wildfires Have Significant Impacts on Respiratory Health Laura Stiles June 9th 2025 Article There were more fires in the span of a 13-year period from 2005 to 2018 than in the previous 2 decades. McKesson ideaShare: Wrapping Up The Week June 25th 2023 Podcast Drug Topics wraps up a great week in Las Vegas at McKesson ideaShare.
Put another way, according to a 2018 article in the European Heart Journal , statin treatment is remarkably safe, with the only risk being that around one in 1000 patients will become exposed to new-onset diabetes mellitus. Food and Drug Administrations (FDA) drug recall page.
Wildfires Have Significant Impacts on Respiratory Health Laura Stiles June 9th 2025 Article There were more fires in the span of a 13-year period from 2005 to 2018 than in the previous 2 decades.
December 2018. link] articles/2018/12/dysmenorrhea-and-endometriosis-in-the-adolescent 4. American Pharmaceutical Association; 2025. Dysmenorrhea and endometriosis in the adolescent. American College of Obstetricians and Gynecologists. Accessed April 28, 2025. Smith RP, Kaunitz AM. UpToDate.
A new drug application for lorundrostat is expected to be filed with the FDA in 2025. 2018 ESC/ESH guidelines for the management of arterial hypertension. 2018; 39: 3021–3104. The most frequent dose limiting adverse effect is hyperkalemia which is dose-related with an incidence of 5% to 7%. mmHg (p = 0.003) and 11.0 Eur Heart J.
SHOW MORE Avatrombopag gains FDA approval for pediatric ITP treatment, offering a new oral option for managing chronic thrombocytopenia in children. It was initially approved in 2018 for thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure. May 21, 2018. January 9, 2023. doi: 10.12701/jyms.2022.00745
SHOW MORE The FDA approved fremanezumab for pediatric migraine prevention, offering a new treatment option for children and adolescents aged 6 to 17. This indication expands on fremanezumab’s initial FDA approval in 2018. This indication expands on fremanezumab’s initial FDA approval in 2018.
The global asthma report 2018. August 31, 2018. Every inhaler needs to be inspected periodically to make sure that it’s still clean and in good shape. 14,18 Conclusion It may seem like counseling on inhaler use could take too much time, but with practice, it can take minutes. REFERENCES Global Asthma Network. Accessed June 6, 2025.
Although 80 mg is the highest dose approved by the Food and Drug Administration (FDA), the benefit from 80 mg over 40 mg isn’t much. One small study published in 2018 found that after six months of therapy, 40 mg reduced LDL-C by 50% and 80 mg reduced it by 52%. One of the most common side effects is muscle aches.
to advanced Liver Fibrosis Date: Jun 19, 2025 Shots: The CHMP has recommended Rezdiffra (resmetirom) for the treatment of adults with noncirrhotic MASH with mod. 2 CR at mFU of 21.9mos., with mDoR of 14.9mos. & & mOS of 15.5mos.
Meloxicam injection (Xifyrm; Azurity Pharmaceuticals, Inc) received FDA approval for use in adults for the management of moderate-to-severe pain, either alone or in combination with non-steroidal anti-inflammatory drug (NSAID) analgesics. August 24, 2018. Schwenk E, Mariano E, et al. Korean Journal of Anesthesiology. Doi:10.4097/kja.d.18.00217
December 13, 2018. American Oncology Network. August 8, 2024. Accessed May 15, 2025. How your oncology peers manage the complexities of care. Oncology Live ®. Accessed May 15, 2025. Desimone R. Improve work performance with a focus on employee development. December 12, 2019. Updated January 19, 2024. Accessed May 15, 2025.
FDA guidance documents illustrate labeling salt drugs and associated active moieties. The secondary label will specify the Drug ZA-ion amount per capsule and the equivalent Drug Z-salt amount consistent with FDA labeling guidance. Additional mole calculations are needed only for drug-name labeling per FDA guidance ( Figure 5b above).
Updated June 4, 2018. Accessed July 22, 2025. link] Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis. ClinicalTrials.gov identifier: NCT02893254. Accessed July 22, 2025.
The Food and Drug Administration (FDA) has approved certain opioids for: Relief of mild to moderate severe pain (e.g., The Food and Drug Administration (FDA) has approved certain opioids for: Relief of mild to moderate severe pain (e.g., What are opioids used for? Imodium (loperamide)) Treatment of opioid addiction (e.g.,
In 2021, the Food and Drug Administration (FDA) approved Wegovy for weight loss in adults with obesity—or who are overweight with at least one weight-related health condition. According to 2017–2018 data, about 31% of Americans were classified as overweight. According to the World Health Organization (WHO) , there were about 1.6
Patients were considered incident users, which included use of both medications in each of the 9 Think Cascade dyads from January 1, 2018, to December 31, 2020. They used data from an Irish national database of prescriptions and included patients 65 years or older.
2018) backed these findings: hesperidin, piperine, and BV, when used together, strengthened the effects of tamoxifen on MCF-7 and T47D cells. 3 In the laboratory setting, work by Khamis et al. This was shown by apoptosis induction and G₂/M phase arrest in most treatment combinations.
Anti-TNFs remain the only FDA-approved class for pediatric IBD, prompting biosimilar use for cost and accessibility. 1,2 The authors wrote that a 2018 survey from the Crohn’s and Colitis Foundation reported that health care professionals expressed discomfort when prescribing biosimilars in the pediatric population compared with adults.
Snow & Dara Katcher Levy In a recent letter to FDA Commissioner Dr. Martin Makary, U.S. Durbins letter addresses FDAs capacity to oversee the increasing volume of DTC advertisements, particularly on platforms like social media. By Charles D. Kennedy Jr., In 2021, the U.S.
SHOW MORE The action follows 2 FDA-issued complete response letters. The FDA approved ketamine (Ketarx; PharmaTher Holdings) for its indicated uses in surgical pain management, according to a news release from the manufacturer. In October, the FDA requested that the manufacturer resubmit for approval by the end of February 2025.
Lewis, , Principal Regulatory Device and Biologics Expert The FDA is currently funded through March 1st, 2025. Come Monday March 3rd, if Congress does not pass a budget or continuing resolution, the FDA will enter a shutdown and shutter many offices and programs while Congress works out their inter-party squabbles on national priorities.
Fentanyl used in healthcare settings is overseen by the FDA. A study published in 2018 found that about 73% (almost 3 in 4) of people giving birth had an epidural. Read on to learn more about the use of fentanyl in epidurals, including safety considerations and how it works for pain management. What is fentanyl used for?
Thus, the reduced number of newly licensed pharmacists versus PharmD graduates: 2 In 2018, there were 14,905 PharmD graduates and 14,103 taking the NAPLEX for the first time. The number of PharmD graduates will likely dip below 10,000 in the next 5 years (a reduction of 33% from 2018).
In the United States, FDA is increasingly reviewing the safety of PFAS in materials that come into contact with pharmaceuticals.International standards for pharmaceutical primary packaging materials may become more stringent in the future to limit the use of PFAS. 2018 (accessed October 2023). OECD Environment Directorate. Fraunhofer.
Due to Ozempic’s newsworthy shortages and a growing demand for more GLP-1 drugs, people started talking about Mounjaro in 2022, when it was approved by the Food and Drug Administration (FDA) for the treatment of Type 2 diabetes. Mounjaro was approved by the FDA in 2022 for the treatment of Type 2 diabetes. The amount of money the U.S.
Aimovig was the first ever FDA-approved CGRP receptor antagonist in 2018. This alternative comes in an auto-injector containing the medication in solution form that is injected under the skin in the abdomen, thigh, or upper arm.
Koblitz & Dara Katcher Levy Promotional claims do not receive the most attention with respect to FDA enforcement these days, and veterinary promotion is no exception. And, going into detail about the primary effectiveness endpoint, FDA raised concerns about claims allegedly exaggerating the speed of action for Zenrelia (i.e.
4 These findings led to the 2017 FDA approval of CPX-351 for adult patients with t-AML or AML-MRC. 2018;(38):555-573. 2017.77.6112 FDA approves first treatment for certain types of poor-prognosis acute myeloid leukemia. 2017.77.6112 FDA approves first treatment for certain types of poor-prognosis acute myeloid leukemia.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content